Related Experiment Video
Updated: Sep 1, 2025

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
329
18F-THK5351 positron emission tomography imaging for Gerstmann-Sträussler-Scheinker disease
Yuka Hama1, Yuji Saitoh2, Etsuko Imabayashi3
1Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-higashi, Kodaira, Tokyo 187-8551, Japan.
Journal of the Neurological Sciences
|August 12, 2022
Summary
No abstract available in PubMed .
Keywords:
Amyloid plaqueAstrogliosisGerstmann-Sträussler-Scheinker diseasePositron emission tomographyPrion proteinTHK5351More Related Videos
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
229
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
229
Positron Emission Tomography
5.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.0K

